MedTrace Logo

Physical Activity Promotion for Breast and Endometrial Cancer Survivors

NCT04262180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2025-10-24

No results posted yet for this study

Summary

Many breast and endometrial cancer survivors do not get enough physical activity. Technology-based interventions can be inexpensive and easy to scale up, however they are not effective for all women. The purpose of this study is test an adaptive physical activity intervention approach that reserves the most resources and support for women who do not fare well with a lower-cost, minimal intervention. The results from this trial will inform the development of scalable physical activity interventions for breast and endometrial cancer survivors.

Conditions

  • Physical Activity
  • Breast Cancer Survivors
  • Endometrial Cancer Survivors

Interventions

OTHER

Base intervention-Fitbit with EHR integration

Every subject will start with a base intervention - Fitbit activity tracker with EHR integration including messages delivered via the EHR's patient portal

OTHER

Coaching Calls

Non-responders to base intervention will be randomized to coaching calls.

OTHER

Online Gym

Non-responders to base intervention will be randomized to online gym.

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Kristen Pickett, Ph.D. · University of Wisconsin, Madison

  • Siobhan Phillips, Ph.D., MPH · Northwestern University, Chicago

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-09
Primary Completion
2025-09-15
Completion
2025-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04262180 on ClinicalTrials.gov